hyperaldosteronism
hyperaldosteronism
Explore linked clinical trials. Standard reference: MONDO:000300975 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks | Bone Diseases, Metabolic, Neoplasms by Site, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, bone disorder, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, hyperaldosteronism, hyperinsulinism, hypertensive disorder, malignant endocrine neoplasm, metabolic disease, musculoskeletal system disorder, neoplasm, paraneoplastic syndrome, vascular disorder | Recruiting | Not stated | 2026-10-08 | NCT03374215 | |
| Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities | Apnea, Arrhythmias, Cardiac, Dyssomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sleep Disorders, Intrinsic, adrenal gland disorder, adrenal gland hyperfunction, atrial fibrillation, cardiovascular disorder, endocrine system disorder, heart disorder, hyperaldosteronism, nervous system disorder, primary aldosteronism, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2026-10-05 | NCT07857044 | |
| Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism | Recruiting | Not applicable | 2026-10-02 | NCT07297745 | |
| Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism | Cushing syndrome, Neoplasms by Histologic Type, adenoma, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, epithelial neoplasm, hyperaldosteronism, neoplasm | Recruiting | Phase 2 | 2026-09-23 | NCT06246357 | |
| Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Not applicable | 2026-09-21 | NCT07673445 | |
| SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-15 | NCT07687160 | |
| [11C]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Not yet recruiting | Not applicable | 2026-09-11 | NCT07814105 | |
| Diagnosing Variable Primary Aldosteronism. | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, primary aldosteronism, vascular disorder | Recruiting | Not stated | 2026-09-08 | NCT05765786 | |
| Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Not yet recruiting | Not applicable | 2026-09-02 | NCT07800858 | |
| Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, primary aldosteronism, vascular disorder | Not yet recruiting | Not applicable | 2026-08-31 | NCT07796048 | |
| A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Phase 2 | 2026-08-31 | NCT07470983 | |
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | Abnormalities, Multiple, Arrhythmias, Cardiac, COVID-19, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Down syndrome, Dyssomnias, Edema, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Hemorrhage, Infant, Newborn, Diseases, Infant, Premature, Diseases, Infections, Inflammation, Kawasaki disease, Lung Injury, Menorrhagia, Menstruation Disturbances, Neurobehavioral Manifestations, Neurologic Manifestations, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, Suppuration, Urogenital Diseases, Uterine Hemorrhage, Ventilator-Induced Lung Injury, Water-Electrolyte Imbalance, adrenal gland disorder, adrenal gland hyperfunction, adrenocortical insufficiency, attention deficit hyperactivity disorder, inattentive type, blood coagulation disease, bronchopulmonary dysplasia, cardiovascular disorder, cellulitis, chromosomal disorder, coagulation protein disease, connective tissue disorder, endocrine system disorder, female reproductive system disorder, heart disorder, heart failure, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, hyperaldosteronism, hyperphosphatemia, hypertensive disorder, inherited blood coagulation disorder, insomnia, intellectual disability, lung disorder, lymphatic system disorder, metabolic disease, nervous system disorder, neurodevelopmental disorder, oppositional defiant disorder, pediatric multisystem inflammatory disease, COVID-19 related, phosphorus metabolism disease, pneumonia, potassium deficiency disease, primary aldosteronism, psychiatric disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection, skin infection, skin vascular disease, sleep-wake disorder, uterine disorder, vascular disorder, vascular hemostatic disease, vasculitis, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-08-21 | NCT04278404 | |
| Prospective Phenotyping of Autonomous Aldosterone Secretion | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism | Active, not recruiting | Not stated | 2026-08-13 | NCT03484130 | |
| EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders | Body Weight, Cushing syndrome, Nutritional and Metabolic Diseases, Overweight, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hyperaldosteronism, hypertensive disorder, neoplasm, nutritional disorder, obesity disorder, overnutrition, paraneoplastic syndrome, primary aldosteronism, vascular disorder | Active, not recruiting | Not applicable | 2026-07-27 | NCT07727356 | |
| Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Active, not recruiting | Not applicable | 2026-07-17 | NCT05405101 | |
| Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma | Neoplasms by Site, adrenal cortex adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, malignant endocrine neoplasm, neoplasm, primary aldosteronism | Not yet recruiting | Not applicable | 2026-07-14 | NCT07700472 | |
| Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test | Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, disease, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Not stated | 2026-07-09 | NCT07691801 | |
| Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Not applicable | 2026-07-07 | NCT07688928 | |
| Biomarkers and Choroidal Neovascularization | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, central serous chorioretinopathy, choroidal neovascularization, endocrine system disorder, eye disorder, hyperaldosteronism, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder | Recruiting | Not stated | 2026-07-07 | NCT04439708 | |
| A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Phase 3 | 2026-07-06 | NCT07007793 | |
| A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Not yet recruiting | Phase 2 | 2026-06-12 | NCT07646535 | |
| Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension | Neoplasms by Site, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, adrenal cortex adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, potassium deficiency disease, vascular disorder | Recruiting | Not applicable | 2026-06-11 | NCT07470580 | |
| Study on the Diagnostic Cut-off Point of 24-hour Urinary Aldosterone Measured by Liquid Chromatography-Tandem Mass Spectrometry in the Diagnosis of Primary Aldosteronism in the Oral Sodium Loading Test | Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland disorder, adrenal gland hyperfunction, disease, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Not stated | 2026-06-09 | NCT07635134 | |
| Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Not stated | 2026-06-02 | NCT07621458 | |
| Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism | Cushing syndrome, Neoplasms by Site, adrenal cortex adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, malignant endocrine neoplasm, neoplasm, primary aldosteronism | Recruiting | Not applicable | 2026-05-08 | NCT05368090 |